Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Eli Lilly and Company (LLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 94,495,544
  • Shares Outstanding, K 1,101,090
  • Annual Sales, $ 21,222 M
  • Annual Income, $ 2,738 M
  • 36-Month Beta 0.35
  • Price/Sales 4.03
  • Price/Cash Flow 18.11
  • Price/Book 6.32

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.06 +1.70%
on 01/02/18
87.41 -2.20%
on 01/12/18
-1.22 (-1.41%)
since 12/19/17
3-Month
81.42 +5.00%
on 11/15/17
89.09 -4.04%
on 12/13/17
-0.87 (-1.01%)
since 10/19/17
52-Week
74.00 +15.53%
on 01/31/17
89.09 -4.04%
on 12/13/17
+8.65 (+11.26%)
since 01/19/17

Most Recent Stories

More News
Noteworthy Friday Option Activity: LLY, IDT, EXPE

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Lilly (Eli) & Co , where a total of 12,407 contracts have traded so far, representing approximately...

LLY : 85.49 (-0.38%)
GALLIPRANT® (grapiprant tablets) Named Best Companion Animal Product for 2017

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, today announced GALLIPRANT®...

LLY : 85.49 (-0.38%)
PETX : 4.75 (-3.26%)
Merck Strong on Confirmatory Phase III Lung Cancer Study

Merck's (MRK) Keytruda in combination with Eli Lilly's Alimta and carboplatin meet dual primary endpoints in a confirmatory phase III study for the first-line treatment of lung cancer.

MRK : 61.28 (+0.25%)
LLY : 85.49 (-0.38%)
EXEL : 28.00 (+0.50%)
RHHBY : 30.6900 (+0.59%)
Nektar Boasts Strong Pipeline, Competition Remains a Woe

Nektar (NKTR) impresses with a strong pipeline of early and late-stage candidates. The company makes a significant progress with its lead candidate, Onzeald, for advanced breast cancer in adults.

AZN : 35.44 (+1.06%)
LLY : 85.49 (-0.38%)
SHPG : 144.99 (-0.48%)
NKTR : 71.59 (+2.04%)
After Yesterday's Decline of 1.53%, Eli Lilly & Co Offers Investors Better Value

Eli Lilly & Co (NYSE:LLY) traded in a range yesterday that spanned from a low of $85.32 to a high of $86.59. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $85.49...

LLY : 85.49 (-0.38%)
Look for Shares of Eli Lilly & Co to Potentially Rebound after Yesterday's 1.53% Sell Off

Eli Lilly & Co (NYSE:LLY) traded in a range yesterday that spanned from a low of $85.32 to a high of $86.59. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $85.49...

LLY : 85.49 (-0.38%)
Innventure and Elanco Announce Strategic Initiative to Commercialize Disruptive Technologies for Animal Health

Innventure and Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY), announced a strategic initiative to explore the development of technologies for animal health. The collaboration builds...

LLY : 85.49 (-0.38%)
Look for Shares of Eli Lilly & Co to Potentially Pullback after Yesterday's 1.01% Rise

Eli Lilly & Co (NYSE:LLY) traded in a range yesterday that spanned from a low of $86.03 to a high of $87.30. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $86.59...

LLY : 85.49 (-0.38%)
Dow 30 Stock Roundup: Boeing Q4 Deliveries Up Y/Y, Success for Merck's Keytruda Combo

The Dow endured a volatile week during which the index hit a fresh record high.

AAPL : 178.46 (-0.45%)
SNP : 83.97 (+1.13%)
KO : 47.16 (+0.60%)
CVX : 131.30 (-0.22%)
JPM : 113.01 (-0.22%)
JNJ : 147.36 (+0.30%)
MRK : 61.28 (+0.25%)
LLY : 85.49 (-0.38%)
GS : 256.12 (+2.05%)
PFE : 36.94 (-0.14%)
BA : 337.73 (-0.71%)
Lilly's Elanco/Aratana's Veterinary Medicine Gets EU Nod

Eli Lilly (LLY) animal health unit Elanco and partner Aratana announce the EU approval of Galliprant for treatment of pain associated with osteoarthritis in dogs.

LLY : 85.49 (-0.38%)
NVS : 86.94 (+0.61%)
EXEL : 28.00 (+0.50%)
PETX : 4.75 (-3.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research...

See More

Key Turning Points

2nd Resistance Point 86.66
1st Resistance Point 86.07
Last Price 85.49
1st Support Level 85.11
2nd Support Level 84.74

See More

52-Week High 89.09
Last Price 85.49
Fibonacci 61.8% 83.33
Fibonacci 50% 81.54
Fibonacci 38.2% 79.76
52-Week Low 74.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.